| FASLG |
FASLG, APT1LG1, FASL, TNFSF6: Tumor necrosis factor ligand superfamily member 6 |
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
4.48 |
Evidence |
|
| SYK |
SYK: Tyrosine-protein kinase SYK |
PLAUR |
PLAUR, MO3, UPAR: Urokinase plasminogen activator surface receptor precursor |
4.48 |
Evidence |
|
| ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
ATP2A3 |
ATP2A3: Sarcoplasmic/endoplasmic reticulum calcium ATPase 3 |
4.48 |
Evidence |
|
| STAT6 |
STAT6: Signal transducer and activator of transcription 6 |
NFATC3 |
NFATC3, NFAT4: Nuclear factor of activated T-cells, cytoplasmic 3 |
4.48 |
Evidence |
|
| STAT6 |
STAT6: Signal transducer and activator of transcription 6 |
PLAUR |
PLAUR, MO3, UPAR: Urokinase plasminogen activator surface receptor precursor |
4.48 |
Evidence |
|
| CSK |
CSK: Tyrosine-protein kinase CSK |
PLAUR |
PLAUR, MO3, UPAR: Urokinase plasminogen activator surface receptor precursor |
4.48 |
Evidence |
|
| SNCA |
SNCA, NACP, PARK1: Alpha-synuclein |
LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
4.48 |
Evidence |
|
| AGTR1 |
AGTR1, AGTR1A, AGTR1B, AT2R1, AT2R1B: Type-1 angiotensin II receptor |
GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
4.48 |
Evidence |
|
| TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
PLAUR |
PLAUR, MO3, UPAR: Urokinase plasminogen activator surface receptor precursor |
4.48 |
Evidence |
|
| CMA1 |
CMA1, CYH, CYM: Chymase precursor |
EDNRB |
EDNRB, ETRB: Endothelin B receptor precursor |
4.48 |
Evidence |
|
| CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
SNCA |
SNCA, NACP, PARK1: Alpha-synuclein |
4.48 |
Evidence |
|
| CAPN3 |
CAPN3, CANP3, CANPL3, NCL1: Calpain-3 |
RELA |
RELA, NFKB3: Transcription factor p65 |
4.48 |
Evidence |
|
| CEBPB |
CEBPB, TCF5, PP9092: CCAAT/enhancer-binding protein beta |
STAT3 |
|
4.48 |
Evidence |
|
| PRKCA |
PRKCA, PKCA, PRKACA: Protein kinase C alpha type |
TBXA2R |
TBXA2R: Thromboxane A2 receptor |
4.48 |
Evidence |
|
| DSP |
DSP: Desmoplakin |
DSG2 |
DSG2: Desmoglein-2 precursor |
4.48 |
Evidence |
|
| DSP |
DSP: Desmoplakin |
FREQ |
FREQ, FLUP, NCS1: Neuronal calcium sensor 1 |
4.48 |
Evidence |
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
PLAUR |
PLAUR, MO3, UPAR: Urokinase plasminogen activator surface receptor precursor |
4.48 |
Evidence |
|
| CCL2 |
CCL2, MCP1, SCYA2: Small-inducible cytokine A2 precursor |
SIGLEC12 |
SIGLEC12, SIGLECL1, UNQ9215/PRO34042, SLG: Sialic acid-binding Ig-like lectin 12 |
4.48 |
Evidence |
|
| CD3G |
CD3G, T3G: T-cell surface glycoprotein CD3 gamma chain precursor |
MKNK2 |
MKNK2, GPRK7, MNK2: MAP kinase-interacting serine/threonine-protein kinase 2 |
4.48 |
Evidence |
|
| CD3E |
CD3E, T3E: T-cell surface glycoprotein CD3 epsilon chain precursor |
MKNK2 |
MKNK2, GPRK7, MNK2: MAP kinase-interacting serine/threonine-protein kinase 2 |
4.48 |
Evidence |
|
| ASGR1 |
ASGR1: Asialoglycoprotein receptor 1 |
KRT6E |
KRT6C, KRT6E: Keratin, type II cytoskeletal 6C |
4.48 |
Evidence |
|
| S100A9 |
S100A9, CAGB, CFAG, MRP14: Protein S100-A9 |
STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
4.48 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
EDAR |
EDAR, DL: Tumor necrosis factor receptor superfamily member EDAR precursor |
4.48 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
BID |
BID: BH3-interacting domain death agonist |
4.48 |
Evidence |
|
| INSR |
INSR: Insulin receptor precursor |
YWHAG |
YWHAG: 14-3-3 protein gamma |
4.48 |
Evidence |
|